Home / My Practice / Cecilia Pascual-Garrido, MD, PhD

Cecilia Pascual-Garrido, MD, PhD

Pascual-Garrido CV

Dr. Pascual-Garrido earned her PhD at Universidad Catolica and her MD at René Favaloro Medical University, both in Buenos Aires, Argentina. She completed residency training in orthopaedic surgery at Hospital Italiano de Buenos Aires. Following her residency, she pursued a postdoctoral research fellowship in the Biochemistry department and a research fellowship in the Cartilage Restoration Center in the departments of Orthopedics and Anatomy and Cell Biology, both at Rush University Medical Center in Chicago. She then completed fellowship training in Sports Medicine and Shoulder Surgery at the Hospital for Special Surgery in New York and Adult Reconstruction and Hip Preservation at the University of Colorado Hospital in Boulder.

Dr. Pascual-Garrido has team physician experience, serving as the Assistant Team Physician for the New York Mets, New York Knicks and the US Open in 2011 and 2012. Prior to joining Washington University Orthopedics, Dr. Pascual-Garrido was an Associate Professor in Hip Preservation at the University of Colorado for 2 years. At the University of Colorado, she treated high-performance athletes including Olympians, college athletes and amateurs. She was also awarded with the ANCHOR hip preservation travelling fellow where she spent time at Boston Children’s Hospital at Harvard Medical School and Mayo Clinic in Rochester, Minnesota learning the contemporary management of the young adult hip.

For the past decade, Dr. Pascual-Garrido has been part of the faculty in the Orthopaedic Department at Washington University in the field of Adult Reconstruction and Hip Preservation where she currently holds the title of Associate Professor. She is an accomplished complex hip surgeon who treats young and adult patients with hip pre-osteoarthritic and advanced osteoarthritis. She performs adult hip reconstruction and hip preservation procedures, including open and arthroscopic complex hip procedures, direct anterior and posterior total hip replacement, revision arthroplasty, PAO, hip arthroscopy, core decompression, proximal femoral osteotomies and hip surgical dislocation.

Dr. Pascual-Garrido has a broad background in basic sciences and clinical orthopedics research with a specific focus on mechanism of disease in the pre-arthritic hip, specifically epigenetic changes that occur in the pre-arthritic hip. She has more than 125 publications in highly rated journals, authored several book chapters, served on the editorial boards of several journals and currently serves on the prestigious AOSSM research committee. Dr. Pascual-Garrido has been awarded with the prestigious ANCHOR Harris Hip Award in Hip Preservation. She also is a member of the following organizations: Academic Network of Conservational Hip Outcomes Research (ANCHOR), American Academy of Orthopedic Surgeons (AAOS), American Association of Hip and Knee Surgeons (AAHKS), American Orthopedic Society for Sports Medicine (AOSSM), International Cartilage Repair Society (ICRS), International Society for Hip Arthroscopy (ISHA), Orthopedic Research Society (ORS) and Ruth Jackson Orthopaedic Society (RJOS). Dr. Pascual-Garrido serves as Director of the ANCHOR fellowship as well.

Over the last ten years, Dr. Pascual has led a basic science lab and has also developed a small animal model of FAI that she will be using as a platform to study progression of hip OA. She has secured extramural funding from the NIH, as well as multiple OREF and AOSSM grants. Dr. Pascual-Garrido is a nationally recognized leader in the field of Hip Preservation and has been awarded by the AAOS for Award of Excellence, the Lee T. Ford Academic Award, the William Harris Career Development Award in Hip Preservation from the ANCHOR Group and the AOSSM Cabaud Memorial Award. She is also a two-time recipient of The Hip Society’s Otto Aufranc Award for her work on “Identification of Key Molecular Players in the Progression of Hip Osteoarthritis through Transcriptomes and Epigenetics” and “DNTM3A-PPARy Signaling is a Key Epigenetic Mechanism of Hip OA Disease: A Potential Therapeutic Target for Hip OA.” Her vision is to utilize her research findings to improve clinical practice and ultimately better patient’s outcomes.